Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 5.19
+0.19 (3.80%)
Jul 10, 2026, 4:08 PM HKT
Sino Biopharmaceutical Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 92,534 | 110,478 | 58,258 | 63,845 | 84,459 | 102,408 | |
Market Cap Growth | 3.48% | 89.64% | -8.75% | -24.41% | -17.53% | -27.33% |
Enterprise Value | 97,568 | 115,449 | 64,462 | 66,382 | 90,167 | 114,126 |
Last Close Price | 5.19 | 6.11 | 3.12 | 3.32 | 4.27 | 4.97 |
PE Ratio | 35.93 | 42.37 | 15.64 | 24.85 | 29.37 | 5.71 |
Forward PE | 18.69 | 21.62 | 17.48 | 17.77 | 20.63 | 12.33 |
PS Ratio | 2.61 | 3.12 | 1.90 | 2.21 | 2.87 | 3.11 |
PB Ratio | 1.98 | 2.36 | 1.28 | 1.52 | 1.97 | 2.21 |
P/TBV Ratio | 3.08 | 3.68 | 1.78 | 1.96 | 2.59 | 2.84 |
P/FCF Ratio | 10.33 | 12.33 | 9.68 | 11.60 | 14.88 | 22.84 |
P/OCF Ratio | 8.95 | 10.69 | 8.28 | 9.55 | 11.93 | 15.55 |
PEG Ratio | 1.19 | 0.84 | 1.24 | 1.34 | - | 0.62 |
EV/Sales Ratio | 2.75 | 3.26 | 2.10 | 2.30 | 3.07 | 3.46 |
EV/EBITDA Ratio | 12.21 | 14.30 | 8.79 | 9.45 | 12.75 | 17.05 |
EV/EBIT Ratio | 14.28 | 16.49 | 10.44 | 11.08 | 14.81 | 20.07 |
EV/FCF Ratio | 10.89 | 12.88 | 10.71 | 12.06 | 15.88 | 25.46 |
Debt / Equity Ratio | 0.38 | 0.38 | 0.23 | 0.33 | 0.37 | 0.33 |
Debt / EBITDA Ratio | 2.19 | 2.19 | 1.39 | 1.97 | 2.22 | 2.21 |
Debt / FCF Ratio | 2.00 | 2.00 | 1.72 | 2.54 | 2.81 | 3.36 |
Net Debt / Equity Ratio | -0.16 | -0.16 | -0.12 | -0.04 | -0.07 | -0.09 |
Net Debt / EBITDA Ratio | -0.95 | -0.95 | -0.74 | -0.22 | -0.45 | -0.65 |
Net Debt / FCF Ratio | -0.86 | -0.86 | -0.90 | -0.28 | -0.56 | -0.97 |
Asset Turnover | 0.45 | 0.45 | 0.45 | 0.41 | 0.42 | 0.50 |
Inventory Turnover | 2.47 | 2.47 | 2.44 | 2.31 | 2.10 | 2.79 |
Quick Ratio | 1.23 | 1.23 | 1.11 | 0.90 | 1.15 | 1.38 |
Current Ratio | 1.37 | 1.37 | 1.26 | 1.05 | 1.29 | 1.53 |
Return on Equity (ROE) | 12.53% | 12.53% | 11.82% | 12.12% | 11.94% | 55.25% |
Return on Assets (ROA) | 5.56% | 5.56% | 5.62% | 5.33% | 5.40% | 5.37% |
Return on Invested Capital (ROIC) | 13.68% | 13.22% | 14.13% | 12.90% | 13.46% | 15.24% |
Return on Capital Employed (ROCE) | 12.40% | 12.40% | 12.70% | 13.30% | 12.30% | 10.30% |
Earnings Yield | 2.82% | 2.36% | 6.39% | 4.02% | 3.40% | 17.51% |
FCF Yield | 9.68% | 8.11% | 10.33% | 8.62% | 6.72% | 4.38% |
Dividend Yield | 2.00% | 1.64% | 2.24% | 1.47% | 2.81% | 1.61% |
Payout Ratio | 64.12% | 64.12% | 52.76% | 27.13% | 49.84% | 6.42% |
Buyback Yield / Dilution | 1.30% | 1.30% | 1.26% | 2.57% | 1.38% | -2.57% |
Total Shareholder Return | 3.30% | 2.94% | 3.51% | 4.04% | 4.19% | -0.96% |